Lv1
60 积分 2022-11-02 加入
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study
13天前
已完结
Circulating Tumor DNA in Early Breast Cancer: A Review
13天前
已完结
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study
14天前
已完结
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
17天前
已完结
Targeting cyclin-dependent kinases in cancer: emerging therapeutics and clinical strategies
18天前
已完结
[Imlunestrant - ER+/HER2-, locally advanced or metastatic breast cancer with an activating ESR1 mutation]
26天前
已关闭
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
30天前
已完结
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
1个月前
已完结
Next-generation sequencing for PTEN testing in HR+/HER2˗ metastatic breast cancer
1个月前
已完结
Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial
1个月前
已完结
皖公网安备34019202002308
